Efficacy and safety of reduced-dose and slow-infusion intravenous alteplase regimen in patients with acute pulmonary embolism at intermediate-high-risk

Back

ESC Professional Premium Access

Efficacy and safety of reduced-dose and slow-infusion intravenous alteplase regimen in patients with acute pulmonary embolism at intermediate-high-risk

Session: Acute pulmonary embolism: new approaches for an old killer

Topic: Pulmonary Embolism (PE)

Speaker: Doctor B. Kultursay (Istanbul, TR)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Barkin Kultursay

Kartal Kosuyolu Heart and Research Hospital, Istanbul (Türkiye)

0 follower

5 more presentations in this session

Elective endovascular reperfusion therapies in intermediate-high risk pulmonary embolism after PERT assesment

Speaker: Doctor I. Cigalini (Rosario, AR)

Impact of a blood return system on mechanical thrombectomy in treatment of acute pulmonary embolism: a retrospective cohort study comparing 30-day mortality and need for blood transfusion

Speaker: Doctor D. Patel (Cleveland, US)

Intracranial haemorrhage following treatment for pulmonary embolism: analysis of the german nationwide inpatient sample

Speaker: Mr K. Christodoulou (Mainz, DE)

White Smoke in the Intermediate risk PE debate, could POPE be the solution?

Speaker: Doctor A. Martins (Lisbon, PT)

Interleukin 21, plasminogen activator inhibitor 1 and fractalkine improve risk stratification in elderly patients with pulmonary embolism

Speaker: Mr M. Matter (Zurich, CH)

Access the full session

Acute pulmonary embolism: new approaches for an old killer

Speakers: Doctor B. Kultursay, Doctor I. Cigalini, Doctor D. Patel, Mr K. Christodoulou, Doctor A. Martins...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources